PENGGUNAAN OBAT DAN BIAYANYA PADA PASIEN PASCA OPERASI KATARAK DI KLINIK MATA X SEMARANG

DOI: https://doi.org/10.31596/cjp.v6i1.182

Lidya Tri Wahyu Setyarini(1), Maria Caecilia Nanny Setiawati(2*), Siti Munisih(3)

(1) Sekolah Tinggi Ilmu Farmasi Yayasan Pharmasi Semarang
(2) Sekolah Tinggi Ilmu Farmasi Yayasan Pharmasi Semarang
(3) Sekolah Tinggi Ilmu Farmasi Yayasan Pharmasi Semarang
(*) Corresponding Author

Abstract


Katarak adalah kekeruhan pada lensa mata yang menyebabkan gangguan penglihatan. Meski banyak usaha yang dilakukan untuk memperlambat progresivitas atau mencegah terjadinya katarak, tatalaksananya adalah dengan pembedahan. Tujuan penelitian untuk mengetahui karakteristik pasien, obat yang digunakan dan biaya obat pada pasien pasca operasi katarak  di Klinik Mata X Semarang periode Januari sampai Maret 2020. Penelitian ini merupakan penelitian deskriptif dengan teknik purposive sampling. Data yang diambil adalah data rekam medis pasien, lembar resep obat dan data keuangan. Hasil penelitian, terdapat 71 pasien terdiri dari pasien wanita sebanyak 39 pasien (54,39%) dan laki-laki sebanyak 32 (45,07%) dengan jumlah total operasi 94 kali. Usia paling banyak pada rentang 61-70 tahun sebesar 43,66%. Obat yang sering digunakan berupa obat tetes mata antiinflamasi berisi Prednisolon asetat (97,87%) dan berisi natrium diclofenak (80,85%) , obat tetes mata antibiotik yang berisi gatifloxasin (56,99%) dan levofloksasin (44,09%). Semua obat yang digunakan adalah obat ber merk dagang (100%), sediaan terbanyak tetes mata (85,92%). Rata-rata biaya obat per operasi katarak adalah Rp 734.510,-, biaya termahal adalah biaya tetes mata berisi antibiotik (25,06%). Rata-rata per pasien mendapat 4,12 obat. Pasca operasi katarak, dokter  memberikan beberapa obat kepada pasien untuk mencegah terjadinya komplikasi pasca pembedahan meliputi terjadinya infeksi (diberi antibiotika untuk profilaksi), dry eye syndrome (diberi artificial tear drops) dan untuk mengurangi rasa nyeri (diberi antiinflamasi). Simpulan yang dapat diambil, wanita usia lanjut lebih banyak menjalani operasi katarak dibanding pria, tetes mata yang paling banyak diresepkan adalah produk yang mengandung antibiotik gatifloksasin dan  antiinflamasi mengandung prednisolon asetat. Rata-rata biaya total obat pasca operasi katarak di Klinik Mata X Semarang adalah Rp 734.510 per kali operasi.


Keywords


katarak; operasi; obat; biaya; klinik mata

Full Text:

PDF

Article Metrics

Abstract viewed : 182 times | PDF files downloaded : 300 times

References


Ahuja, J., Gupta, M., Gupta, A. K., & Kohli, K. (2004). Pharmacoeconomics. The National Medical Journal of India, 17(2), 80–83.

Allen, D., & Vasavada, A. (2006). Cataract and surgery for cataract. BMJ : British Medical Journal, 333(7559), 128–132.

Bodrogi, J., & Kaló, Z. (2010). Principles of pharmacoeconomics and their impact on strategic imperatives of pharmaceutical research and development. British Journal of Pharmacology, 159(7), 1367–1373. https://doi.org/10.1111/j.1476-5381.2009.00550.x

Cunha, P. A. F. da, Shinzato, F. A., Tecchio, G. T., Weber, S. L. P., Brasil, A., & Avakian, A. (2013). Efficacy and tolerability of a gatifloxacin/prednisolone acetate fixed combination for topical prophylaxis and control of inflammation in phacoemulsification: A 20-day-double-blind comparison to its individual components. Clinics, 68, 834–839. https://doi.org/10.6061/clinics/2013(06)18

Espiritu, C. R. G., & Bolinao, J. G. (2017). Prophylactic intracameral levofloxacin in cataract surgery – an evaluation of safety. Clinical Ophthalmology, 11, 2199–2204. https://doi.org/10.2147/OPTH.S144625

Favuzza, E., Cennamo, M., Vicchio, L., Giansanti, F., & Mencucci, R. (2020).

Protecting the Ocular Surface in Cataract Surgery: The Efficacy of the Perioperative Use of a Hydroxypropyl Guar and Hyaluronic Acid Ophthalmic Solution

. Clinical Ophthalmology, 14, 1769–1775. https://doi.org/10.2147/OPTH.S259704

Garg, P., Gupta, A., Tandon, N., & Raj, P. (2020). Dry Eye Disease after Cataract Surgery: Study of its Determinants and Risk Factors. Turkish Journal of Ophthalmology, 50(3), 133–142. https://doi.org/10.4274/tjo.galenos.2019.45538

Hossain, M. M., Mohiuddin, A. A., Hossain, M. A., & Aziz, M. A. (2010). Diclofenac sodium and prednisolone acetate ophthalmic solution in controlling inflammation after cataract surgery. Mymensingh Medical Journal: MMJ, 19(3), 343–347.

Kartikasari, Nursanyoto, Yoga, (2015), jurnal Virgin jilid 1, no 1, januari 2015

Kerry D Solomon, Helga P Sandoval and Richard Potvin, Comparing Combination Drop Therapy to a Standard Drop Regimen After Routine Cataract Surgery, Clinical Ophthalmology, 10 July 2020 Volume 2020:14 Pages 1959—1965, DOI https://doi.org/10.2147/OPTH.S260926

Kessel, L., Tendal, B., Jørgensen, K. J., Erngaard, D., Flesner, P., Andresen, J. L., & Hjortdal, J. (2014). Post-cataract Prevention of Inflammation and Macular Edema by Steroid and Nonsteroidal Anti-inflammatory Eye Drops. Ophthalmology, 121(10), 1915–1924. https://doi.org/10.1016/j.ophtha.2014.04.035

Lai, K., Cui, J., Ni, S., Zhang, Y., He, J., & Yao, K. (2013). The Effects of Postmenopausal Hormone Use on Cataract: A Meta-Analysis. PLoS ONE, 8(10), e78647. https://doi.org/10.1371/journal.pone.0078647

Matossian, C. (2020). Noncompliance with Prescribed Eyedrop Regimens Among Patients Undergoing Cataract Surgery—Prevalence, Consequences, and Solutions. http://www.touchophthalmology.com/cataract-surgery/journal-articles/noncompliance-with-prescribed-eyedrop-regimens-among-patients-undergoing-cataract-surgery-prevalence-consequences-and-solutions/

Michael, R., & Bron, A. J. (2011). The ageing lens and cataract: A model of normal and pathological ageing. Philosophical Transactions of the Royal Society B: Biological Sciences, 366(1568), 1278–1292. https://doi.org/10.1098/rstb.2010.0300

Price, M. O., & F. W. Price, J. (2004). Effect of Gatifloxacin Ophthalmic Solution 0.3% on Corneal Endothelial Cell Counts in Normal Subjects and in Cataract Surgery Patients. Investigative Ophthalmology & Visual Science, 45(13), 4935–4935.

Solomon, K. D., Sandoval, H. P., & Potvin, R. (2020).

Comparing Combination Drop Therapy to a Standard Drop Regimen After Routine Cataract Surgery

. Clinical Ophthalmology, 14, 1959–1965. https://doi.org/10.2147/OPTH.S260926

Spector, A. (1995). Oxidative stress-induced cataract: Mechanism of action. The FASEB Journal, 9(12), 1173–1182. https://doi.org/10.1096/fasebj.9.12.7672510

Wirakusumah, E., 2001. Menu Sehat Untuk Lanjut Usia, Jakarta

Worzala, K., Hiller, R., Sperduto, R. D., Mutalik, K., Murabito, J. M., Moskowitz, M., D’Agostino, R. B., & Wilson, P. W. F. (2001). Postmenopausal Estrogen Use, Type of Menopause, and Lens Opacities: The Framingham Studies. Archives of Internal Medicine, 161(11), 1448–1454. https://doi.org/10.1001/archinte.161.11.1448

Youngson,R.,2005. Antioxsidants : Vitamin A & C for health. Alih bahasa : Susi Purwoko,

Arcan, Jakarta

Zafar, S., Wang, P., Schein, O. D., Srikumaran, D., Makary, M., & Woreta, F. A. (2020). Prescribing Patterns and Costs Associated with Postoperative Eye Drop Use in Medicare Beneficiaries Undergoing Cataract Surgery. Ophthalmology, 127(5), 573–581. https://doi.org/10.1016/j.ophtha.2019.11.005

Zetterberg, M., & Celojevic, D. (2015). Gender and Cataract – The Role of Estrogen. Current Eye Research, 40(2), 176–190. https://doi.org/10.3109/02713683.2014.898774




DOI: https://doi.org/10.31596/cjp.v6i1.182

Refbacks

  • There are currently no refbacks.


Journal Indexed by:

Google Scholar OneSearch Garuda Ristekdikti PKP Index Crossref

Copyright of Cendekia Journal of Pharmacy. ISSN: 2599-2163 (Print) dan 2599-2155 (Online).

Creative Commons License
This work is licensed under a Creative Commons Attribution 2.0 Generic License. Web
Analytics View My Stats